Genetics of adult glaucoma

International Ophthalmology Clinics

Volumn 51, Issue 3, 2011, Pages 37-51

  Challa, Pratap ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COLLAGEN; CYTOCHROME P450 1B1; DEXAMETHASONE; ELASTIN; LEUCINE ZIPPER PROTEIN; LYSL OXIDASE; LYSL OXIDASE LIKE 1; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; MUTANT PROTEIN; MYOCILIN; OLFACTOMEDIN; OPTINEURIN; PROTEIN P53; RAB8 PROTEIN; RIBOSOME RNA; TROPOELASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WDR 36;

ADULT DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AQUEOUS HUMOR; AQUEOUS HUMOR OUTFLOW; ARGON LASER; ARTICLE; CADAVER; CELL DEATH; CELL SHAPE; CHROMOSOME 5Q; CILIARY BODY EPITHELIUM; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXON; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GLAUCOMA; HEREDITY; HUMAN; INTRAOCULAR HYPERTENSION; IRIS; LEBER HEREDITARY OPTIC NEUROPATHY; LOW TENSION GLAUCOMA; MISSENSE MUTATION; MYELIN SHEATH; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; ONSET AGE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PHENOTYPE; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOEXFOLIATION; RETINA GANGLION CELL; RISK FACTOR; SCHLEMM CANAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRABECULAR MESHWORK; TRABECULOPLASTY; VISUAL FIELD DEFECT; ZEBRA FISH;

ADULT; AMINO ACID OXIDOREDUCTASES; CHILD; CYTOSKELETAL PROTEINS; EXFOLIATION SYNDROME; EYE PROTEINS; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; GLYCOPROTEINS; HUMANS; TRANSCRIPTION FACTOR TFIIIA;

EID: 79958110410     PISSN: 00208167     EISSN: 15369617     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31821e52fe     Document Type: Article

References (121)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393. (Pubitemid 26158268)
2. Thylefors B, Negrel AD, Pararajasegaram R, et al. Global data on blindness. Bull World Health Organ. 1995;73:115-121.
3. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369-374.
4. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994;112:69-73. (Pubitemid 24024503)
5. Wolfs RC, Klaver CC, Ramrattan RS, et al. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol. 1998;116: 1640-1645. (Pubitemid 29001963)
6. Sarfarazi M. Recent advances in molecular genetics of glaucomas. Hum Mol Genet. 1997;6:1667-1677. (Pubitemid 27401609)
7. Armaly MF. Inheritance of dexamethasone hypertension and glaucoma. Arch Ophthalmol. 1967;77:747-751.
8. Tawara A, Inomata H. Developmental immaturity of the trabecular meshwork in juvenile glaucoma. Am J Ophthalmol. 1984;98:82-97. (Pubitemid 14089540)
9. PolanskyJR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthal-mologica. 1997;211:126-139. (Pubitemid 27223561)
10. Sheffield VC, Stone EM, Alward WL, et al. Genetic linkage offamilial open angle glaucoma to chromosome 1q21-q31.Nat Genet. 1993;4:47-50. (Pubitemid 23165911)
11. Stone EM, FingertJH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670. (Pubitemid 27061334)
12. Allingham RR, Wiggs JL, De La Paz MA, et al. Gln368 STOP myocilin mutation in families with late-onset primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2288-2295. (Pubitemid 28485640)
13. Angius A, Spinelli P, Ghilotti G, et al. Myocilin Gln368 STOP mutation and advanced age as risk factors for late-onset primary open-angle glaucoma. Arch Ophthalmol. 2000;118:674-679. (Pubitemid 30327345)
14. FingertJH, Heon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899-905. (Pubitemid 29189058)
15. Kennan AM, Mansergh FC, FingertJH, et al. A novel Asp380Ala mutation in the GLC1A/myocilin gene in a family withjuvenile onset primary open angle glaucoma. JMedGenet. 1998;35:957-960. (Pubitemid 28486628)
16. Mabuchi F, Yamagata Z, Kashiwagi K, et al. Analysis of myocilin gene mutations in Japanese patients with normal tension glaucoma and primary open-angle glaucoma. Clin Genet. 2001;59:263-268. (Pubitemid 32318393)
17. Mabuchi F, Yamagata Z, Kashiwagi K, et al. A sequence change (Arg158Gln) in the leucine zipper-like motif region of the MYOC/TIGR protein. J Hum Genet. 2001;46:85-89. (Pubitemid 32231259)
18. Mansergh FC, Kenna PF, Ayuso C, et al. Novel mutations in the TIGR gene in early and late onset open angle glaucoma. Hum Mutat. 1998;11:244-251. (Pubitemid 28132882)
19. Suzuki R, Hattori Y, Okano K. Promoter mutations of myocilin gene inJapanese patients with open angle glaucoma including normal tension glaucoma. Br J Ophthalmol. 2000;8:1078.
20. Taniguchi F, Suzuki Y, Shirato S, et al. The Gly367Arg mutation in the myocilin gene causes adult-onset primary open-angle glaucoma. Jpn J Ophthalmol. 2000;44: 445-448.
21. Vasconcellos JP, Melo MB, Costa VP, et al. Novel mutation in the MYOC gene in primary open glaucoma patients.J Med Genet. 2000;37:301-303. (Pubitemid 30245938)
22. Suzuki Y, Shirato S, Taniguchi F, et al. Mutations in the TIGR gene in familial primary open-angle glaucoma inJapan. Am J Hum Genet. 1997;61:1202-1204. (Pubitemid 27492331)
23. Challa P, Herndon LW, Hauser MA, et al. Prevalence of myocilin mutations in adults with primary open-angle glaucoma in Ghana, West Africa.J Glaucoma. 2002;11: 416-420.
24. Alward WL, Kwon YH, Khanna CL, et al. Variations in the myocilin gene in patients with open-angle glaucoma. Arch Ophthalmol. 2002;120:1189-1197. (Pubitemid 35034342)
25. Shimizu S, Lichter PR, Johnson AT, et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol. 2000;130: 165-177.
26. Alward WL, FingertJH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med. 1998;338:1022-1027.
27. Kubota R, KudohJ, Mashima Y, et al. Genomic organization of the human myocilin gene (MYOC) responsible for primary open angle glaucoma (GLC1A). Biochem BiophysRes Commun. 1998;242:396-400. (Pubitemid 28412439)
28. Fingert JH, Ying L, Swiderski RE, et al. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 1998;8:377-384. (Pubitemid 28209976)
29. Kubota R, Noda S, Wang Y, et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics. 1997;41:360-369. (Pubitemid 27194787)
30. Ortego J, Escribano J, Coca-Prados M. Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett. 1997;413:349-353. (Pubitemid 27353298)
31. Adam MF, Belmouden A, Binisti P, et al. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet. 1997;6:2091-2097. (Pubitemid 27477951)
32. FingertJH, ClarkAF, CraigJE, et al. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42:145-152.
33. Taniguchi F, Suzuki Y Kurihara H, et al. Molecular cloning of the bovine MYOC and induction of its expression in trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2000;41:2070-2075. (Pubitemid 30450975)
34. Taguchi M, Kanno H, Kubota R, et al. Molecular cloning and expression profile of rat myocilin. Mol Genet Metab. 2000;70:75-80. (Pubitemid 30396207)
35. Russell P, Tamm ER, Grehn FJ, et al. The presence and properties of myocilin in the aqueous humor Invest Ophthalmol Vis Sci. 2001;42:983-986. (Pubitemid 32289793)
36. Nguyen TD, Chen P, Huang WD, et al. Gene structure and properties ofTIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem. 1998;273:6341-6350. (Pubitemid 28144725)
37. Snyder DA, Rivers AM, Yokoe H, et al. Olfactomedin: purification, characterization, and localization of a novel olfactory glycoprotein. Biochemistry. 1991;30:9143-9153.
38. Karavanich C, Anholt RR. Evolution of olfactomedin. Structural constraints and conservation ofprimary sequence motifs. Ann N YAcad Sci. 1998;855:294-300.
39. Anholt RR, Petro AE, Rivers AM. Identification of a group of novel membrane proteins unique to chemosensory cilia of olfactory receptor cells. Biochemistry. 1990;29:3366-3373. (Pubitemid 20131482)
40. Moreno TA, Bronner-Fraser M. The secreted glycoprotein Noelin-1 promotes neurogenesis in Xenopus. Dev Biol. 2001;240:340-360. (Pubitemid 34056496)
41. Karali A, Russell P, Stefani FH, et al. Localization ofmyocilin/ trabecular meshwork-inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci. 2000;41:729-740. (Pubitemid 30158883)
42. Ricard CS, Agapova OA, Salvador-Silva M, et al. Expression of myocilin/TIGR in normal and glaucomatous primate optic nerves. Exp Eye Res.2001;73:433-447. (Pubitemid 33078220)
43. Ohlmann A, Goldwich A, Flugel-Koch C, et al. Secreted glycoprotein myocilin is a component of the myelin sheath in peripheral nerves. Glia. 2003;43:128-140. (Pubitemid 36897274)
44. Kim BS, Savinova OV, Reedy MV, et al. Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function. MolCell Biol. 2001;21:7707-7713. (Pubitemid 32988780)
45. Rao PV, Allingham RR, Epstein DL. TIGR/myocilin in human aqueous humor Exp Eye Res. 2000;71:637-641. (Pubitemid 32002250)
46. Tamm ER, Russell P Epstein DL, et al. Modulation of myocilin/TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1999;40:2577-2582. (Pubitemid 29455486)
47. Wang X, Johnson DH. mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork. Invest Ophthalmol Vis Sci. 2000;41:1724-1729. (Pubitemid 30354343)
48. Takahashi H, Noda S, Mashima Y, et al. The myocilin (MYOC) gene expression in the human trabecular meshwork. Curr Eye Res. 2000;20:81-84. (Pubitemid 30099158)
49. Huang W, Jaroszewski J, Ortego J, et al. Expression of the TIGR gene in the iris, ciliary body, and trabecular meshwork of the human eye. Ophthalmic Genet. 2000;21:155-169.
50. Swiderski RE, RossJL, FingertJH, et al. Localization ofMYOC transcripts in human eye and optic nerve by in situ hybridization. Invest Ophthalmol Vis Sci. 2000;41: 3420-3428.
51. Mackey DA, Healey DL, FingertJH, et al. Glaucoma phenotype in pedigrees with the myocilin Thr377Met mutation. Arch Ophthalmol. 2003;121:1172-1180.
52. Wilkinson CH, Van Der Straaten D, Craig JE, et al. Tonography demonstrates reduced facility of outflow of aqueous humor in myocilin mutation carriers. JGlaucoma. 2003;12:237-242. (Pubitemid 36736725)
53. Fautsch MP, Bahler CK, Jewison DJ, et al. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci. 2000;41: 4163-4168.
54. Borras T, Rowlette LL, Erzurum SC, et al. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther. 1999;6:515-524. (Pubitemid 29192660)
55. Caballero M, Rowlette LL, Borras T Altered secretion of a TIGR/MYOC mutant lacking the olfactomedin domain. Biochim Biophys Acta. 2000;1502:447-460.
56. Gould DB, Reedy M, Wilson LA, et al. Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Mol Cell Biol. 2006;26:8427-8436. (Pubitemid 44748576)
57. Senatorov V, Malyukova I, Fariss R, et al. Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J Neurosci. 2006;26: 11903-11914. (Pubitemid 44772101)
58. Zhou Y, Grinchuk O, Tomarev SI. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest Ophthalmol Vis Sci. 2008; 49:1932-1939.
59. Johnson DH. Myocilin and glaucoma: a TIGR by the tail? Arch Ophthalmol. 2000;118:974-978. (Pubitemid 30460638)
60. Jacobson N, Andrews M, Shepard AR, et al. Non-secretion ofmutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor Hum Mol Genet. 2001;10:117-125. (Pubitemid 32098121)
61. Caballero M, Borras T Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma. Biochem Biophys Res Commun. 2001;282:662-670. (Pubitemid 32924607)
62. Caballero M, Liton PB, Challa P et al. Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. Biochem Biophys Res Commun. 2004;323: 1048-1054. (Pubitemid 39243424)
63. Alward WL. The genetics ofopen-angle glaucoma: the story of GLC1Aand myocilin. Eye. 2000;14:429-436. (Pubitemid 30479744)
64. Lam DS, Leung YF, ChuaJK, et al. Truncations in the TIGR gene in individuals with andwithoutprimaryopen-angle glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1386-1391. (Pubitemid 30261861)
65. Wiggs JL, Vollrath D. Molecular and clinical evaluation of a patient hemizygous for TIGR/MYOC. Arch Ophthalmol. 2001;119:1674-1678. (Pubitemid 33035710)
66. Morissette J, Clepet C, Moisan S, et al. Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet. 1998;19:319-321. (Pubitemid 28357899)
67. HewittAW, Bennett SL, Dimasi DP, et al. Amyocilin Gln368 STOP homozygote does not exhibit a more severe glaucoma phenotype than heterozygous cases. Am J Ophthalmol. 2006;141:402-403. (Pubitemid 43188058)
68. Bruttini M, Longo I, Frezzotti P, et al. Mutations in the myocilin gene in families with primary open-angle glaucoma and juvenile open-angle glaucoma. Arch Ophthalmol. 2003;121:1034-1038. (Pubitemid 36841797)
69. Jansson M, Marknell T, Tomic L, et al. Allelic variants in the MYOC/TIGR gene in patients with primary open-angle, exfoliative glaucoma and unaffected controls. Ophthalmic Genet. 2003;24:103-110. (Pubitemid 36566903)
70. Faucher M, Anctil JL, Rodrigue MA, et al. Founder TIGR/myocilin mutations for glaucoma in the Quebec population. Hum Mol Genet. 2002;11:2077-2090. (Pubitemid 34993996)
71. VincentAL, Billingsley G, Buys Y, et al. Digenic inheritance ofearly-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet. 2002;70:448-460. (Pubitemid 34112298)
72. Brown MD, Voljavec AS, Lott MT, et al. Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases. FASEBJ. 1992;6:2791-2799.
73. Sarfarazi M, Child A, Stoilova D, et al. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet. 1998;62:641-652. (Pubitemid 28164622)
74. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077-1079. (Pubitemid 34132238)
75. Alward WL, Kwon YH, Kawase K, et al. Evaluation of optineurin sequence variations in 1048 patients with open-angle glaucoma. Am J Ophthalmol. 2003;136:904-910. (Pubitemid 37330036)
76. Leung YF, Fan BJ, Lam DS, et al. Different optineurin mutation pattern in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44:3880-3884. (Pubitemid 37047958)
77. Wiggs JL, Auguste J, Allingham RR, et al. Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma. Arch Ophthalmol. 2003;121:1181-1183. (Pubitemid 36962173)
78. Hauser MA, Sena DF, FlorJ, et al. Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States.J Glaucoma. 2006;15:358-363. (Pubitemid 44434987)
79. Aung T, Rezaie T, Okada K, et al. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci. 2005;46:2816-2822. (Pubitemid 43086703)
80. CraigJE, Hewitt AW, Dimasi DP, et al. The role of the Met98Lys optineurin variant in inherited optic nerve diseases. Br J Ophthalmol. 2006;90:1420-1424. (Pubitemid 44702073)
81. Forsman E, Lemmela S, Varilo T, et al. The role ofTIGR and OPTN in Finnish glaucoma families: a clinical and molecular genetic study. Mol Vis. 2003;9:217-222. (Pubitemid 38097590)
82. Li Y, KangJ, Horwitz MS. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol. 1998;18:1601-1610. (Pubitemid 28100926)
83. VittitowJ, Borras T Expression ofoptineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure. Biochem Biophys Res Commun. 2002;298:67-74. (Pubitemid 35205388)
84. De Marco N, Buono M, Troise F, et al. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus.J Biol Chem. 2006;281:16147-16156. (Pubitemid 43848510)
85. Kroeber M, Ohlmann A, Russell P, et al. Transgenic studies on the role of optineurin in the mouse eye. Exp Eye Res. 2006;82:1075-1085.
86. Park B, Ying H, Shen X, et al. Impairment of protein trafficking upon over-expression and mutation ofoptineurin. PLoS One. 2010;5:e11547.
87. Chi ZL, Akahori M, Obazawa M, et al. Overexpression of optineurin E50 K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol. Genet. 2010;19:2606-2615.
88. Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223-226.
89. Gaton DD, SagaraT, LindseyJD, et al. Increased matrixmetalloproteinases 1,2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment. Arch Ophthalmol. 2001;119:1165-1170. (Pubitemid 32730004)
90. Bradley JM, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1beta and TNFalpha. Invest Ophthalmol Vis Sci. 2000;41:422-430. (Pubitemid 30080445)
91. Monemi S, Spaeth G, DaSilva A, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet. 2005;14:725-733. (Pubitemid 40403270)
92. Kramer PL, Samples JR, Monemi S, et al. The role of the WDR36 gene on chromosome 5q22.1 in a large family with primary open-angle glaucoma mapped to this region. Arch Ophthalmol. 2006;124:1328-1331. (Pubitemid 44379868)
93. Pasutto F, Mardin CY, Michels-Rautenstrauss K, et al. Profiling of WDR 36 missense variants in German patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49:270-274.
94. Miyazawa A, Fuse N, Mengkegale M, et al. Association between primary open-angle glaucoma and WDR36 DNA sequence variants in Japanese. Mol Vis. 2007;13: 1912-1919. (Pubitemid 47628298)
95. Frezzotti P, Pescucci C, Papa FT, et al. Association between primary open-angle glaucoma (POAG) and WDR36 sequence variance in Italian families affected by POAG. Br J Ophthalmol. 2011;95:624-626.
96. Fingert JH, Alward WL, Kwon YH, et al. No association between variations in the WDR36 gene and primary open-angle glaucoma. Arch Ophthalmol. 2007;125: 434-436. (Pubitemid 46425592)
97. Hewitt AW, Dimasi DP, Mackey DA, et al. A Glaucoma Case-control Study of the WDR36 Gene D658G sequence variant. Am J Ophthalmol. 2006;142:324-325. (Pubitemid 44107276)
98. Hauser MA, Allingham RR, Linkroum K, et al. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2006;47:2542-2546. (Pubitemid 351639839)
99. Mao M, Biery MC, Kobayashi SV, et al. T lymphocyte activation gene identification by coregulated expression on DNA microarrays. Genomics. 2004;83:989-999. (Pubitemid 38726048)
100. SkarieJM, Link BA. The primary open-angle glaucoma gene WDR36 functions in ribosomal-RNA processing and interacts with the p53 stress-response pathway. Hum Mol Genet. 2008;17:2474-2485. Epub 2008 May 10.
101. Chi ZL, Yasumoto F, Sergeev Y, et al. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice. Hum Mol Genet. 2010;19:3806-3815.
102. Karger RA,Jeng SM,Johnson DH, et al. Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J Glaucoma. 2003;12:193-197.
103. Forsius H. Exfoliation syndrome in various ethnic populations. Acta Ophthalmol Suppl. 1988;184:71-85.
104. Lantukh VV, Piatin MM. Features of ocular pathology among the indigenous inhabitants of Chukotka. Vestn Of talmol. 1982;4:18-20.
105. Forsius H. Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos, and Russians. Trans Ophthalmol Soc UK. 1979;99:296-298. (Pubitemid 10074872)
106. Ringvold A. Epidemiology of glaucoma in northern Europe. Eur J Ophthalmol. 1996;6:26-29. (Pubitemid 26144902)
107. Tarkkanen AH. Exfoliation syndrome. Trans Ophthalmol Soc UK. 1986;105:233-236. (Pubitemid 16083298)
108. Richardson TM, Epstein DL. Exfoliation glaucoma: a quantitative perfusion and ultrastructural study. Ophthalmology. 1981;88:968-980. (Pubitemid 11060924)
109. Schlotzer-Schrehardt U, Naumann GO. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci. 1995;36:1750-1764.
110. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317: 1397-1400. (Pubitemid 47417481)
111. Challa P, Schmidt S, Liu Y, et al. Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis. 2008;14:146-149. (Pubitemid 351193745)
112. Fan BJ, Pasquale L, Grosskreutz CL, et al. DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity. BMC Med Genet. 2008;9:5.
113. Fingert JH, Alward WL, Kwon YH, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. Am J Ophthalmol. 2007;144:974-975.
114. Hayashi H, Gotoh N, Ueda Y, et al. Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am J Ophthalmol. 2008;145: 582-585.
115. Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower pene-trance than in Nordic people. Hum Mol Genet. 2008;17:710-716. (Pubitemid 351292259)
116. Ramprasad VL, George R, Soumittra N, et al. Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis. 2008;14:318-322. (Pubitemid 351279917)
117. Williams SE, Whigham BT, Liu Y, et al. Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Mol Vis. 2010;16:705-712.
118. Rautenbach RM, Bardien S, HarveyJ, et al. An Investigation Into LOXL1 Variants in Black South African Individuals With Exfoliation Syndrome. Arch Ophthalmol. 2011;129:206-210.
119. Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36:178-182. (Pubitemid 38174378)
120. Khan TT, Li G, Navarro ID, et al. LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma. Mol Vis. 2010;16:2236-2241.
121. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997;277:997-1003. (Pubitemid 27142370)